Jonathan S. Myers, MD, reports that intraocular drug delivery systems could help solve the problem of poor adherence in patients taking glaucoma medications. Implanted in the eye, the systems would allow for glaucoma drugs to gradually dissolve or elute medication.
Ocular surface disease (OSD) and dry eye disease (DED) are very common problems in the elderly, and they both considerably decrease vision-related quality of life.
Ocular allergy affects the quality of life of millions of people every year. Understanding the different mechanisms involved will increase their future therapeutic options.
Compared with SLT, PSLT appears to offer some advantages, such as a shorter duration of treatment and more comfort for patients.
British installation artist, Luke Jerram, and researchers at Bristol Vision Institute, are creating something that will raise awareness about the nature of cerebral visual impairment in an artist’s residency at the University of Bristol in the United Kingdom.
A novel glistening-free IOL has been tested in 94 eyes and found to give good visual outcomes with a low incidence of PCO
Five ophthalmologists share how to make the most of a co-managed relationship for smoother patient handoff, improved preoperative experiences, and better postoperative outcomes.
OT blogger Donna Suter shares the essential keys to success from master entrepreneur Danny Meyer, founder of Shake Shack. Implementing his tips will make your practice flourish!
Josh Mali, MD, shares his predictions for the 2018 ophthalmic year.
An artificial vision device (MyEye, OrCam) has helped a blind veteran regain his independence, according to the charity Scottish War Blinded.